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Abstract: In the novel approach suggested
here, we examined the use of polypeptide
probes selected from artificial peptide
libraries for the identification of the
differences in dsDNA sequences which are
potential targets for the genetic diseases. As
a model system two target DNAs which are
the polymerase chain reaction (PCR)
products of the two phage–display vector
multiple cloning sites (MCS) differing at 18
base pair long has been used. In the
production of the target sequences
biotinylated primers were used in PCR. The
polypeptide probes obtained from artificial
peptide library by the selection of
phage–display techniques. Identified clones
bearing the candidate polypeptide probe
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Introduction
The identification and recognition of the differences
present in between the DNA sequences under interest is
the major task for the investigation at molecular level in
different fields of medical sciences. The recognition of
DNA sequences has a wide range of applications either for
the detection of the target DNA sequences and
modulation of the target genes. For example; the
presence of various kinds of mutations of β–thalassemia
makes the molecular diagnosis of this disorder
time–consuming despite the availability of various
powerful molecular techniques, complicating the rapid
diagnosis (1). Many research and development
laboratories show great effort to identify the problem
target showing abnormal genetic composition of the
genes either cis–and/or trans–acting factors under
interest. Most of these techniques use DNA–DNA
interaction like polymerase chain reaction (PCR), dot blot
hybridization, reverse blotting etc. On the other hand; the
modulation of the gene expression becomes important
task in tracing the expression of some genes responsible

specific to the target sequences was tested by
phage–ELISA. For the comparison and
selection assays, magnetic separation
technique was used. One clone selected from
artificial peptide library specifically
recognized the 18 nucleotide difference,
which encodes (His)6, in between two model
PCR products and showed no cross reaction
determined by phage–ELISA. These findings
may be interpreted to the usage of the
polypeptides for the detection of the
anomalies at specific target DNA sequences
and be used for the manipulation of the gene
expression in different disease models.
Key Words: Phage display,
detection, polypeptide probes.

mutation

for defined function in case of modelling the protein
targets under interest. DNA–DNA interaction based
techniques have many technical limiting factors like the Tm
of the interacting probe and target DNA sequences. The
use of peptide libraries offers a series of powerful
approaches for the discovery of new biological and
pharmaceutical reagents (2). Peptides offering high
affinity for a particular targets can be identified by
selecting from the phage display libraries containing
numerous number of individual peptide sequences
providing a rich source of novel sequences and structures.
Combinatorial approaches have recently been extended to
the exploration of DNA–binding mofits in proteins
permitting new insights into structural requirements for
protein–DNA interaction (3). In our approach, that we
suggest here, it will promisingly contribute for the
establishment of new detection systems for the quick
identification of the target DNA sequences and
manipulation of the gene expression under interest at
DNA level by the use of peptide structures selected from
artificial random peptide libraries.
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Materials and Methods

pCOCK1

Target sequence preparation
The multiple cloning sites of the two phagemid
vecors, pCOCK1 and pDUCK1 used in phage–display
technology, were modelled as target DNA sequences.
These vectors were obtained from Dr. G Himmler
(Institute of Applied Microbiology, Vienna Austria). Target
dsDNA sequences, differing only 18 bp sequence, were
obtained from these two vector DNAs by PCR
amplification using specific primers spanning the MCS
(“Multiple Cloning Site”) of the vector DNAs (Figures 1,
2). PCR was carried out principally according to the
method of Saiki et al (4). Each amplification tube
contained 50 mM KCl, 10 mM Tris–HCl (pH=8.3), 1.3
mM MgCl2, 2 µM forward primer, 2 µM biotinylated
reverse primer, 0.2 mM each dNTP, 0.1 µg of template
DNA and 1.0 U of Taq Polymerase (Boehringer
Mannheim) in a total volume of 50 µl. The PCR cycles
were done by Biometra Trio thermocycler. The cycles
comprised incubations of 1 min at 95°C, 2 min 55°C and
2 min 72°C. In total, 30 cycles were performed and PCR
tubes incubated at 72°C for 10 min. After PCR cycles, the
PCR products were checked with 1.2% Agarose Gel and
purified with Agarose DNA Purification Kit (Boehringer
Mannheim).
Preparation of 16–mer peptide library
The 16–mer artificial peptide library was prepared at
Tübitak Marmara Research Center (5). Main sequence
was synthesized with Cruachem PS250 DNA Synthesizer
and cloned into phagemid vector pCOCK1 as described in
figure 3.
Selection of target specific phage–diplayed clones
Phagemid clones displaying specific peptide sequences
on their surfaces, were selected by biopanning procedure

MCS

c–myc tag

pDUCK1

Figure 1.

267 bp PCR PRODUCT

(6–9). Since the main aim was to identify the binder
peptide sequence specific to the 18 nucleotide present on
the pDUCK1 MCS in our model, comparatively selection
strategy was followed (Figure 4). Selection was started
with the 5’–biotinylated PCR product of pDUCK1. 1 µl of
the PCR product was mixed with 1x1010 tfu phagemid
library in a total volume of 100 µl in PBS (phosphate
buffered saline), and incubated at 37°C for 30 minutes.
After incubation at 37°C, 20 µl streptavidin coated
magnetic particles (Dynal) was added into the
microcentrifuge tube. Biotinylated PCR product–binded
phagemid complex was removed by applying magnetic
field and remained unbound phagemids were washed out
by PBS. Collected phagemids were eluted by the addition
of 100 µl E. Coli (TG1) suspension. Microcentrifuge tube
was incubated at 37°C for 1 hour, the elution mix was
titrated and amplified to 1x1010 tfu for the second round
of panning. In the second round of panning the collected
phagemids were panned against biotinylated PCR product
of pCOCK1 to remove phagemids recognizing the regions
on the DNA sequence other than 18 bp target sequence
encoding for the (His)6. To be able to obtain this result, in
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pDUCK1

285 bp PCR PRODUCT

(His)6

The characteristics of the target DNAs used in the model
system (MCS–Multiple cloning site).

Figure 2.

pCOCK1

AMBER STOP

1

2

M

Preparation of target sequences,
differing at 18 nucleotides, for
phage–displayed artificial library
selection.
(M:
Marker,
1419–517–396–214 bp in size,
1: PCR product of pDUCK1, 2:
PCR product of pCOCK1)
– ) Biotinylated
( ) Biotin ( ––>
5’–primer ( <––
) 3’–primer ( )
–
18
nucleotide
sequence
encoding (His)6.

E. Ö. ATALAY, B. ERDAĞ, B. ÇIRAKOĞLU

Phage ELISA

(NNS)16

SfiI

Not I

(100–mer Oligonucleotide)

FIRST STRAND
SYNTHESIS

PCR

The clones obtained after the comparative selection,
were subjected to Phage–ELISA according to the modified
procedure of Clackson et al (10) as described in figure 5.
The positive clones selected by phage–ELISA were
accepted as binder phagemids displaying specific peptide
sequences on their surface fused to protein 3. Single
colonies were inoculated into 200 µl of 2xTY–Tet6 and
grown with shaking for 20–24 hours at 37°C in 96–well
PVC ELISA plate. Following centrifugation 25 µl of each
supernatant was transferred to the 500 µl
microcentrifuge tubes. 2 µl of target sequences which are
PCR products carrying biotin added to the supernatants
under interest and the binder phagemid–target complexes
were collected with streptavidin–coated magnetic
particles (Dynal) and detected by anti–pCOCK1 antibody
AP (alkaline phosphatase) conjugate according to the
procedure given by McCafferty et al (14).
Results

Cloning the 100 bp PCR product into
vector pCOCK1 by using the
restriction enzymes Sfi I and Not I

Figure 3.

Preparation of the artificial 16–mer peptide library.
(N → A, C, G, T)
(S → G, C).

the second round of panning unbound phagemids were
collected instead of bound phagemids. Unbound phages
obtained from the second run were subjected to the third
round of panning against biotinylated PCR product of
pDUCK1 to enrich the specific phagemids against 18 bp
sequence under interest.

Target sequences were prepared by PCR primers
corresponding to the multiple cloning sites (MCS) of the
vectors pCOCK1 and pDUCK1 vector DNAs differing at
18 nucleotides (Figure 2). To be able to determine the
clones recognizing the 18–nucleotide difference, 16–mer
artificial peptide library prepared in our group was
interacted with the target DNA sequences by the method
of bio–panning as described in method section.
After three rounds of comparative selection, the
specific DNA binding clones were reselected by
phage–ELISA, as described in Materials and Methods
(figures 4, 5). Table 1 shows the phage ELISA results
belonging 10 clones out 1000 clones selected. In total 3
clones accepted as positive and coded as EPIDUCK03,
EPIDUCK05 and EPIDUCK08 which give OD405 values of

TARGET–A

TARGET–B

FIRST ROUND OF
PANNING

Figure 4.

Comparative selection strategy
of specific binding phagemid
clones.
Target–A: 5’–Biotinylated PCR
product of pDUCK1
Target–B: 5’–Biotinylated PCR
product of pCOCK1

SECOND ROUND OF
PANNING
TARGET–A
CLONES SPECIFIC
TO THE TARGET–A
ARE COLLECTED

THIRD ROUND OF
PANNING
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Figure 5.

The main strategy on the
magnetic particle directed
phage–ELISA.

5’–BIOTINYLATED PCR PRODUCTS
AND PHAGEMID CLONES INCUBATED
IN SOLUTION AT 37°C

PHAGEMID–PCR PRODUCT COMPLEX
CAPTURED BY STREPTAVIDIN COATED
MAGNETIC PARTICLES

AP

THE PRESENCE OF THE INTERACTION IN
BETWEEN PHAGEMID CLONE AND PCR
PRODUCT IS FOLLOWED BY THE ANTI–
PHAGEMID CONJUGATED ALKALINE
PHOSPHATASE

1.043, 1.044 and 1.739 respectively. Table 2 shows the
phage–ELISA results for the possible cross–reactivity in
between two target sequences under interest, and no
cross reaction was observed with the clone named
EPIDUCK08. The other two clones, EPIDUCK03 and
EPIDUCK05 gave high OD405 values against the target
DNA sequence which do not contain (His)6 coding
nucleotides,
compared
to
EPIDUCK08.
The
cross–reaction experiment was repeated with the clone
EPIDUCK08 by phage–ELISA and obtained the same
results.
Discussion
EPIDUCK03 and EPIDUCK05 binds to the target–A,
pCOCK1–MCS PCR product. But EPIDUCK08 binds to the
target–B, pDUCK1–MCS PCR product much more
efficiently (table 2). According to these data, EPIDUCK08
shows high OD405 values against target–B, pDUCK1–MCS
PCR product compared to the target–A, pCOCK1–MCS
PCR product and wild type pCOCK1 shows background
level compared to the negative control well.
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Table 1.

ELISA results for the selected clones after three rounds of
selection.

CLONES

OD405

EPIDUCK01
EPIDUCK02
EPIDUCK03
EPIDUCK04
EPIDUCK05
EPIDUCK06
EPIDUCK07
EPIDUCK08
EPIDUCK09
EPIDUCK10
Negative Control(*)

0.329
0.740
1.043
0.385
1.044
0.282
0.738
1.739
0.161
0.121
0.077

(*)

Negative Control: No target DNA.

Our results confirm the use of peptide libraries
offering a series of powerful approaches for the discovery
of new biological and pharmaceutical reagents stated by

E. Ö. ATALAY, B. ERDAĞ, B. ÇIRAKOĞLU

Table 2.

ELISA results of the positive clones for the cross–reactivity
in between two target sequences.

CLONES
EPIDUCK03
EPIDUCK05
EPIDUCK08

TARGET–A

TARGET–B

0.838
0.920
0.280

1.088
1.200
1.388

TARGET–A: pCOCK1–MCS PCR product
TARGET–B: pDUCK1–MCS PCR product
Negative Control: No target DNA (0.075)

Devlin et al (2). Since the recombinant antibody
technology with its applications provides a very diverse
range of subjects like in health, agricultural and
environmental sciences (12), the use of artificial peptide
libraries offering high affinity for a particular targets
identified by selecting from the phage display libraries
containing numerous number of individual peptide
sequences providing a rich source of novel sequences and
structures can be used in different fields of science while
considering the DNA sequences as specific targets under
interest. Combinatorial approaches have recently been
extended to the exploration of DNA–binding motifs in
proteins permitting new insights into structural

requirements for protein–DNA interaction (3). In our
case; phagemid clone, EPIDUCK08, recognized the target
sequence much more efficiently in solution compared to
the immobilized state, due to possible conformational
changes occurred (data not shown). In our case, the
selected phagemid clone can discriminate the difference in
18 nucleotides present in between two, 267 and 285 bp
in size, double stranded sequences. On the other hand,
the binding experiment was carried under 37°C which
means that multiple probing is possible with different
peptide probes, in case of the identification of the
different problem targets on DNA like different type of
deletions, frameshifts and/or mutations responsible for
the observed function of thalassemias and abnormal
hemoglobins. The novel approach that we suggest here
will promisingly contribute the establishment of new
detection systems for the quick identification of the
differences of DNA sequences under interest and possible
manipulation of gene expression at DNA level by the use
of peptide structures selected from artificial random
peptide libraries.
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